Advances in stem cell transplantation leads to a changing landscape in treating blood cancers, such as lymphoma, leukemia, and multiple myeloma.
The expert who created an assessment tool to help patients with myeloproliferative neoplasms explain their symptoms to their care ream shares how the idea came to fruition.
An Extraordinary Healers essay honoring Barbara Wilson, RN, OCN, CRNI, BSN [Simonds-Sinon Regional Cancer Center in Fitchburg, Massachusetts]
An Extraordinary Healer essay honoring DANIELLE PINKERTON, B.S.N., CPN [ST. JUDE CHILDREN’S RESEARCH HOSPITAL, MEMPHIS, TENNESSEE]
Supriya Mohile, director of the Geriatric Oncology clinic at the University of Rochester Wilmot Cancer Institute, explains that when geriatric patients visit their doctors and oncologists, it is important to express their worries and any side effects that they are experiencing.
The Hairy Cell Leukemia Foundation will host a free patient forum on July 17th with guest speaker Dr. Martin Tallman from Memorial Sloan Kettering Cancer Center. This forum is free and open to the public and will cover a range of issues related to patients’ journey with hairy cell leukemia.
This essay nominating registered nurse Wendy Sconce for CURE®'s 2019 Extraordinary Healer® Award was written by Peggy Hufty of SSM Health Cancer Care, Lake St. Louis, Missouri.
Yoga has earned accolades as a complementary therapy, and now studies are confirming its value.
An Extraordinary Healer essay honoring KATHLEEN MORRISON, RN, OCN [ST. FRANCIS HOSPITAL, ROSLYN, NEW YORK]
Amanda Bontempo, MS, RD, CSO, CDN, gives some tips for healthy eating. Join us on 4/18 at 1 PM for our tweetchat, with Bontempo as moderator, to discuss more nutrition.
The Food and Drug Administration has approved the combination use of Venclexta plus Gazyva for the frontline treatment of patients with chronic lymphocytic leukemia or small lymphocytic lymphoma.
Getting a second opinion after a cancer diagnosis is considered a routine, essential and necessary component of one’s health care plan, but many people are reluctant to seek one.
The EndBrainCancer Initiative wants patient concerns reflected in national treatment guidelines.
One cancer survivor details how her immunotherapy changed her cancer journey for the better, and how ongoing trials of immunotherapy are looking to change the cancer landscape for the better.
On taking a mental health break from cancer in order to rekindle a sense of hope.
An Extraordinary Healer essay honoring TINA FLOCCO, APN-BC, AOCNP [REGIONAL CANCER CARE ASSOCIATES, EAST BRUNSWICK, NEW JERSEY]
There's a heartbreaking reality of making a profession out of cancer, but I chose it anyway.
Carole Brennan Miller, M.D., head of the Cancer Institute at Saint Agnes Hospital, explains what makes people with myeloproliferative neoplasms (MPNs) unique, and why she finds it interesting to work with them.
Rural patients tend to have diminished access to appropriate, routine cancer screening studies, leading to patients with cancer being diagnosed with more advanced stage disease.
Catriona Jamieson, M.D., Ph.D., Professor of Medicine, University of California, San Diego Health Moores Cancer Center, addresses a common myth about clinical trials.
Rebecca N. Claassen discusses the importance of educating nurses about myeloproliferative neoplasms (MPNs).
Jame Abraham, Director of Cleveland Clinic's Breast Medical Oncology Program, provides an overview of what you shouldn't be afraid to ask your doctor.
Exercise can help prevent excess fatigue for survivors of cancer and other issues are explored in this summer issue of CURE.
Melanoma rates are on the rise, and is the most common form of cancer for young adults aged 25 to 29 years old.
The massive search for new drug candidates, amid haystacks of possibilities.
I haven’t written about cancer for about three months. That’s a long time for me.